Image:
Watchdog: “No evidence” Greensill supply-chain finance had any benefit
A new report from the National Audit Office has found “no evidence” that the predicted benefits and savings from Greensill Capital’s supply-chain finance scheme for pharmacies were realised.
The report comes following an investigation into Greensill Capital, which once claimed to be the UK's most valuable financial technology company, that began after its collapse in March. It analyses...
To continue reading this article...
Join Investment week
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
